Clinical Trial

Investigating Neural Biomarkers for Gait in Parkinson's Patients

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 3, 2024 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
This observational study's main goal is to learn more about the neural mechanisms during movement in Parkinson's disease. Furthermore, it aims to inspire personalised treatment options. Participants will undergo a protocol that involves walking and gait-related motor tasks, such as seated stepping. During the protocol, brain activity will be recorded.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-04-06; most recent amendment 2024-11-28.
Status change: Not Yet Recruiting → Recruiting 2023-09-12
Trial Details
NCT Number NCT05820074
Lead Sponsor Swiss Federal Institute of Technology
Collaborators: cereneo center for Neurology and Rehabilitation, University of Zurich
Conditions Parkinson Disease, Gait Disorders, Neurologic
Enrollment 60 participants
Start Date 2023-04-13
Primary Completion 2025-03 (estimated)
Study Completion 2025-03 (estimated)
Updated on ClinicalTrials.gov 2024-12-03